NCT05389423 2026-06-01Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting25 enrolled
NCT02071888 2018-07-18Study of the Glutaminase Inhibitor CB-839 in Hematological TumorsCalithera Biosciences, IncPhase 1 Completed25 enrolled